Full Fiscal Year 2015 Revenue Was $190.3 Million Generated $17.4 Million Adjusted EBITDA and $7.0 Million Net Income in Fiscal Year 2015 Company Provides Fiscal 2016 Guidance; Expects to Achieve Increased Revenue, Operating Margin and EPS Outlines Plan for Continued NASDAQ Listing SALT LAKE CITY ,
SALT LAKE CITY , Aug. 24, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), announced today that Mark Jaggi has been appointed Chief Financial Officer for the company effective August 24, 2015 . Mr. Jaggi is a highly experienced finance and operations executive, having spent the past
SALT LAKE CITY , Aug. 21, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) announced today that it will release financial results for its fourth quarter and full year ended June 30, 2015 , after the stock market closes on Tuesday, September 1, 2015 .
Fiscal Year 2015 Revenue and Earnings Per Share Results In-Line with Previous Guidance Full Fiscal Year 2015 Revenue was Approximately $190 Million SALT LAKE CITY , Aug. 10, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) today announced preliminary results for the fourth quarter
SALT LAKE CITY , July 08, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), has announced that its flagship product, Protandim, has been registered in Mexico as an Herbal Medicine. The company is planning to begin shipping Protandim to Mexico in the second quarter, fiscal 2016.
Revenue During First Nine Months of Fiscal Year 2015 in the Americas Increased 2.8% Repurchased $9.9 Million of Common Stock in First Nine Months of Fiscal Year 2015 Reduced Long-Term Debt by $3.5 Million in First Nine Months of Fiscal Year 2015 Reaffirms Fiscal Year 2015 Outlook Range SALT LAKE